| Literature DB >> 35814141 |
Andreas Hinz1, Markus Zenger2,3, Bjarne Schmalbach4, Elmar Brähler1,5, Dirk Hofmeister1, Katja Petrowski4.
Abstract
Objectives: Quality of life (QoL) has been the focus of increasing interest in oncology. QoL assessment instruments implicitly assume that each QoL domain has the same meaning for each patient. The objective of this study was to analyze the importance of and the satisfaction with QoL domains and to analyze the relationship between the two.Entities:
Keywords: breast cancer; importance; psycho-oncology; quality of life; satisfaction
Year: 2022 PMID: 35814141 PMCID: PMC9257209 DOI: 10.3389/fpsyg.2022.923537
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Sociodemographic characteristics of the sample of cancer patients (n = 308) and the general population sample (n = 1143).
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| Age | ||||
| ≤59 years | 68 | 22.1 | 269 | 23.5 |
| 60–69 years | 107 | 34.7 | 409 | 35.8 |
| ≥70 years | 133 | 43.2 | 465 | 40.7 |
| Civil status | ||||
| Living without partner | 105 | 34.1 | 450 | 39.4 |
| Living with partner | 202 | 65.6 | 693 | 60.6 |
| Missing | 1 | 0.3 | 0 | 0 |
| Education | ||||
| ≤9 years | 89 | 28.9 | 551 | 48.2 |
| 10–11 years | 146 | 47.4 | 432 | 37.8 |
| ≥12 years | 71 | 23.1 | 160 | 14.0 |
| Missing | 2 | 0.6 | 0 | 0 |
| Time since diagnosis | ||||
| ≤5 years | 165 | 53.6 | ||
| >5 years | 143 | 46.4 | ||
| Chemotherapy | ||||
| No | 157 | 51.0 | ||
| Yes | 151 | 49.0 | ||
| Radiotherapy | ||||
| No | 50 | 16.2 | ||
| Yes | 258 | 83.8 | ||
| Hormone therapy | ||||
| No | 143 | 46.4 | ||
| Yes | 158 | 51.3 | ||
| Missing | 7 | 2.3 | ||
Importance and satisfaction ratings (range: 1–5).
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||
|
|
|
|
|
|
|
|
|
|
| |
| Importance | ||||||||||
| Friends | 3.59 | 0.83 | 3.57 | 0.89 | 3.63 | 0.85 | −0.02 | 0.712 | 0.07 | 0.127 |
| Leisure time | 3.20 | 0.96 | 3.31 | 0.89 | 3.29 | 0.84 | 0.12 | 0.070 | −0.02 | 0.554 |
| Health | 4.62 | 0.60 | 4.39 | 0.61 | 4.49 | 0.58 | – |
|
|
|
| Income | 4.05 | 0.71 | 4.08 | 0.73 | 4.09 | 0.74 | 0.04 | 0.513 | 0.01 | 0.870 |
| Work | 3.15 | 1.38 | 4.02 | 0.75 | 4.10 | 0.71 |
|
| 0.11 | 0.084 |
| Housing | 3.92 | 0.72 | 4.12 | 0.66 | 4.16 | 0.65 |
|
| 0.06 | 0.389 |
| Family life | 4.09 | 0.89 | 4.43 | 0.72 | 4.44 | 0.67 |
|
| 0.01 | 0.910 |
| Partner | 3.17 | 1.28 | 3.13 | 1.47 | 3.28 | 1.43 | −0.04 | 0.638 | 0.12 | 0.127 |
| Satisfaction | ||||||||||
| Friends | 3.86 | 0.79 | 4.01 | 0.90 | 4.04 | 0.80 |
|
| 0.04 | 0.436 |
| Leisure time | 3.64 | 0.85 | 3.76 | 0.90 | 3.74 | 0.85 |
|
| −0.02 | 0.649 |
| Health | 3.44 | 0.95 | 3.36 | 1.07 | 3.35 | 1.06 | −0.08 | 0.202 | −0.01 | 0.714 |
| Income | 3.41 | 0.93 | 3.54 | 0.99 | 3.59 | 0.96 |
|
| 0.05 | 0.104 |
| Work | 3.36 | 1.03 | 3.57 | 0.96 | 3.63 | 0.94 |
|
| 0.06 | 0.147 |
| Housing | 4.01 | 0.79 | 4.28 | 0.74 | 4.31 | 0.71 |
|
| 0.04 | 0.602 |
| Family life | 3.93 | 0.90 | 4.31 | 0.87 | 4.35 | 0.87 |
|
| 0.05 | 0.511 |
| Partner | 3.27 | 1.18 | 3.59 | 1.27 | 3.61 | 1.28 |
|
| 0.02 | 0.272 |
M, mean; SD, standard deviation; ES, effect size; GP, general population; italics, statistically significant.
Relationship between importance and satisfaction; test-retest-correlations.
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |
| Friends |
|
|
|
|
|
|
|
|
|
|
| Leisure time |
|
|
|
|
|
|
|
|
|
|
| Health |
|
| 0.07 | 0.190 | 0.05 | 0.379 |
|
|
|
|
| Income |
|
| −0.01 | 0.874 | 0.04 | 0.525 |
|
|
|
|
| Work |
|
| 0.08 | 0.136 | 0.09 | 0.101 |
|
|
|
|
| Housing |
|
|
|
|
|
|
|
|
|
|
| Family life |
|
|
|
|
|
|
|
|
|
|
| Partner |
|
|
|
|
|
|
|
|
|
|
Italics, statistically significant.
Correlation and regression analyses, predicting global QoL from importance, satisfaction, and the interaction of importance and satisfaction, for patients at t1 and t2.
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
| ||
| Patients at t1 | |||||||||||
| Friends |
|
|
|
| 0.02 | 0.682 |
|
| 0.02 | 0.799 | 0.24 |
| Leisure time |
|
|
|
| −0.02 | 0.688 |
|
| 0.11 | 0.146 | 0.38 |
| Health |
|
|
|
|
|
|
|
| 0.08 | 0.249 | 0.43 |
| Income | 0.02 | 0.660 |
|
| 0.03 | 0.612 |
|
| −0.05 | 0.486 | 0.27 |
| Work | 0.03 | 0.614 |
|
| 0.00 | 0.985 |
|
| 0.05 | 0.410 | 0.33 |
| Housing |
|
|
|
| 0.05 | 0.395 |
|
| −0.01 | 0.848 | 0.30 |
| Family life |
|
|
|
| 0.02 | 0.727 |
|
| 0.05 | 0.471 | 0.23 |
| Partner |
|
|
|
| 0.02 | 0.736 |
|
| 0.07 | 0.355 | 0.29 |
| Patients at t2 | |||||||||||
| Friends |
|
|
|
| 0.11 | 0.065 | 0.14 | 0.149 |
|
| 0.45 |
| Leisure time |
|
|
|
| 0.10 | 0.060 |
|
|
|
| 0.48 |
| Health |
|
|
|
|
|
|
|
| −0.01 | 0.936 | 0.64 |
| Income | 0.09 | 0.099 |
|
| 0.08 | 0.117 |
|
| 0.06 | 0.381 | 0.39 |
| Work | 0.07 | 0.225 |
|
| 0.04 | 0.484 |
|
| 0.07 | 0.274 | 0.39 |
| Housing | 0.11 | 0.054 |
|
| 0.02 | 0.782 |
|
| 0.09 | 0.180 | 0.27 |
| Family life | 0.05 | 0.346 |
|
| −0.05 | 0.421 |
|
| 0.06 | 0.441 | 0.24 |
| Partner | 0.10 | 0.078 |
|
| −0.02 | 0.785 | 0.16 | 0.112 | 0.15 | 0.075 | 0.27 |
Italics, statistically significant.